A carregar...
Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
Background: Claims included in package inserts (PIs) for medicinal products approved by the US Food and Drug Administration (FDA) constitute the regulatory definition of drugs’ benefits and risks. Objective: We sought to assess the usage of patient-reported outcome (PRO) claims in a comprehensive se...
Na minha lista:
| Publicado no: | J Mark Access Health Policy |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Routledge
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5956285/ https://ncbi.nlm.nih.gov/pubmed/29785254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1433426 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|